University of Colorado Anschutz

Official Twitter account of #CUAnschutz, the largest academic health center in the Rocky Mountain region. This is where dreams live.

[University of Colorado Anschutz @CUAnschutz]

Healing, discovery and hope happen when we dream and work in concert with each other. From restoring sound and sight to advancing brain health, #CUAnschutz is leading research that brings new hope to patients everywhere.

✨ Never dream alone. https://t.co/zfv0hFaA12

[University of Colorado Anschutz @CUAnschutz]

Peptide injectables are gaining attention online, but many have not undergone the testing required for FDA approval. A #CUAnschutz medical toxicologist discusses the science and safety concerns surrounding these compounds. 👇
https://t.co/xeQnizTC6v

[University of Colorado Anschutz @CUAnschutz]

A new drug developed by #CUAnschutz researchers may offer a different approach to treating alcohol use disorder. The drug, Nezavist, works to target gut-brain communication rather than acting directly on the brain. 💊
https://t.co/f1O6ZTv0ZD

[Stiff Person Syndrome Research Foundation @TheSPSRF]

What an incredible weekend at the 2026 SPS Symposium! Thank you to every attendee — in person and virtual — and a huge shoutout to Dr. Amanda Piquet and the team at @CUAnschutz for hosting and volunteering. We are so grateful! #SPSRF #StiffPersonSyndrome

[Medical Xpress @medical_xpress]

An 80% cut to syringe program funding could mean 39,600 additional deaths in five years among US people who inject drugs, including 15,600 from overdose, according to modeled projections. @cuanschutz @jamanetworkopen https://t.co/uER4CclBiY

[University of Colorado Anschutz @CUAnschutz]

After nearly a decade unable to walk without assistance, Colorado resident Lynn Montgomery-Haga is walking freely again.

Lynn was the first patient enrolled in a #CUAnschutz CAR T-cell trial that could transform treatment for stiff person syndrome.

🔗: https://t.co/O0t7tVkLzA

[Thomas Flaig @TomFlaigMD]

Researchers at @CUAnschutz are working to better understand & prevent type 1 diabetes. Read how the campus’s renowned Barbara Davis Center for Diabetes is advancing research to slow disease progression and guide future therapies.
https://t.co/xAklZOSS8Q

[Pain Medicine News @painmednews]

Not all post-amputation pain is the same. New CU Anschutz study shows separating pain types can boost comfort, mobility & recovery for amputees. Learn how prosthetic design impacts pain: https://t.co/bNzdewIdDA #Amputation #PainResearch #Rehab #Prosthetics

[CU Anschutz Cancer Center @CUCancerCenter]

The U.S. News & World Report has released its 2026-2027 Best Global Universities rankings. We're proud of our oncologists for their tireless efforts in the fight against cancer. This ranking of @CUAnschutz reflects their work: https://t.co/tgzw9y568r

[CU Anschutz Lymphoma Program @CULymphoma]

Our @CULymphoma lead Dr. @mana1981 contributed to a multicenter study, now published @BloodCancerJnl, describing outcomes of MCL after BR and BTK inhibitors. #lymsm #tcellrx
https://t.co/3cBvGuIkQ9

[University of Colorado Anschutz @CUAnschutz]

Bemotrizinol is the first new ingredient approved by the FDA for sunscreens in two decades. 🌞 #CUAnschutz dermatologist Theresa Pacheco, MD, shares how this chemical sunscreen works differently to block the sun's rays.
https://t.co/LjXUIBo3YG

[CU Anschutz Department of Medicine @CUDeptMedicine]

50+ future residents and countless possibilities ahead 🤩

We're excited to officially welcome our newest residents to the CU Anschutz Internal Medicine family! We're looking forward to supporting this talented group as they learn, grow, and begin the next chapter of their medical careers. 🌟💙

[Physician's Weekly @physicianswkly]

🩺 #mCRC care is officially past the era of “treat first, sort it out later.”

At #ASCO2026, Dr. Lieu (@CUAnschutz ) made the case: early biomarker testing+upfront personalized therapy=better outcomes. Full stop.

Watch▶️ https://t.co/M9ovlR1qNx

#OncTwitter #CRC

[University of Colorado Anschutz @CUAnschutz]

#CUAnschutz researchers have published a proof-of-concept study demonstrating that injectable #semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (#PMOS), formerly known as #PCOS https://t.co/XCdcu0dix7

[University of Colorado Anschutz @CUAnschutz]

A #CUAnschutz gene therapy study is showing positive results for patients with urea cycle disorder—a rare disease that can lead to brain damage and even death. 🧠 Researchers will likely move forward to study infants and children next.

https://t.co/An8u8ZEQd8

[University of Colorado Anschutz @CUAnschutz]

Research from #CUAnschutz suggests a father’s stress before conception may influence a child’s growth. Scientists found that stress can change tiny molecules in sperm that may help shape development from the earliest stages of life.

🔗 Learn more: https://t.co/YpgkUzWdmI

[CU Anschutz Cancer Center @CUCancerCenter]

It's #NationalCancerSurvivorsDay. In this article, Jennifer Diamond, MD, discusses the roles of both clinical trial researchers and participants and how they affect the rise in cancer survivorship: https://t.co/lpti8xGPnS

[CU Anschutz College of Nursing @NursingCU]

A new study by our midwives in the Journal of Midwifery & Women's Health examines factors that may increase the risk of a C-section and the important role midwives play in providing supportive, evidence-based care. https://t.co/669XMUDsOh

@ACNMmidwives @cuanschutz

[University of Colorado Anschutz @CUAnschutz]

Pancreatic cancer remains one of the most difficult cancers to treat. #CUAnschutz oncologist Christopher Lieu, MD, spoke with @ConversationUS about a new drug that has nearly doubled overall survival in patients with advanced pancreatic cancer: https://t.co/iBDc9PvHJD.

[University of Colorado Anschutz @CUAnschutz]

The Rocky Mountain MS Center at #CUAnschutz is home to one of the largest multiple sclerosis research programs in the world.

From groundbreaking discoveries to clinical trials and emerging therapies, our researchers are advancing care and improving lives: https://t.co/3QFYzN6ivQ

[CU Anschutz Ludeman Center @LudemanCenter]

Congratulations to Ludeman Center Associate Director Jane Reusch, MD, for being recognized at the 2026 Distinguished Faculty Professionalism Awards at @CUAnschutz for her research on diabetes metabolism, exercise intolerance & women’s health. Read more.

https://t.co/iHuXB0MRtT